Cargando…
Interleukin-6 as surrogate marker for imaging-based hypoxia dynamics in patients with head-and-neck cancers undergoing definitive chemoradiation—results from a prospective pilot trial
PURPOSE: Intratumoral hypoxia increases resistance of head-and-neck squamous cell carcinoma (HNSCC) to radiotherapy. [(18)F]FMISO PET imaging enables noninvasive hypoxia monitoring, though requiring complex logistical efforts. We investigated the role of plasma interleukin-6 (IL-6) as potential surr...
Autores principales: | Rühle, Alexander, Wiedenmann, Nicole, Fennell, Jamina T., Mix, Michael, Ruf, Juri, Stoian, Raluca, Thomsen, Andreas R., Vaupel, Peter, Baltas, Dimos, Grosu, Anca-L., Nicolay, Nils H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8940848/ https://www.ncbi.nlm.nih.gov/pubmed/34773163 http://dx.doi.org/10.1007/s00259-021-05602-x |
Ejemplares similares
-
The value of plasma hypoxia markers for predicting imaging-based hypoxia in patients with head-and-neck cancers undergoing definitive chemoradiation
por: Rühle, Alexander, et al.
Publicado: (2022) -
Hypoxia dynamics on FMISO-PET in combination with PD-1/PD-L1 expression has an impact on the clinical outcome of patients with Head-and-neck Squamous Cell Carcinoma undergoing Chemoradiation
por: Rühle, Alexander, et al.
Publicado: (2020) -
(18)F-FMISO-PET Hypoxia Monitoring for Head-and-Neck Cancer Patients: Radiomics Analyses Predict the Outcome of Chemo-Radiotherapy
por: Carles, Montserrat, et al.
Publicado: (2021) -
Optimization of hippocampus sparing during whole brain radiation therapy with simultaneous integrated boost—tutorial and efficacy of complete directional hippocampal blocking
por: Popp, Ilinca, et al.
Publicado: (2022) -
Cost effectiveness and health-related quality of life of chemoradiotherapy versus radiation therapy alone in elderly head and neck cancer patients
por: Sprave, Tanja, et al.
Publicado: (2022)